SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYPB - Cypress BioScience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: muddphudd who wrote (259)6/1/1998 4:15:00 PM
From: Jay Lowe  Read Replies (2) of 586
 
OK ... will edit together an issue list.

Another of my holdings is transiting a hot spot, so my SI
time is going there right now ... it'll be a couple of days.

Another point about the FDA news is that the big investors
have already largely priced approval into the stock ... they
are assuming the approval. The real question becomes can CYPB
get into the market ... can they get those docs out there to
pick up their pads and write "Prosorba" or whatever.

That's the key. We know it works. We can guess the FDA will pass it.
Will Cypress be able to market it? To what extent will the docs
pick up on it? That's the key. If they do, this is a $10 stock, if not, not.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News